STAT5b in LGL Leukemia &Ndash; A Novel Therapeutic Target?

Oncotarget - United States
doi 10.18632/oncotarget.1035
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Lymphocyte Activation Gene 3: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Haematologica
Hematology
2017English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide

Cancer Research
Cancer ResearchOncology
2012English

STAT5BN642H Drives Transformation of NKT Cells: A Novel Mouse Model for CD56+ T-LGL Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

A Guilt-By-Association Mutation Network in LGL Leukemia

Oncotarget
Oncology
2017English

HDAC6 &Ndash; An Emerging Target Against Chronic Myeloid Leukemia?

2020English

DOCK2: A Novel FLT3/ITD Leukemia Drug Target

Oncotarget
Oncology
2017English

Integrin Alpha4 as a Therapeutic Target of Acute Lymphoblastic Leukemia

Journal of Blood Disorders & Transfusion
2014English

Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy